developpement pharmaceutique

The health and pharmaceutical markets face increasingly complex requirements: enhanced stability for fragile molecules, the need for controlled release, and millimeter-precise dosing of actives. For manufacturers, the challenge is to transform often unstable active ingredients or excipients into high-performance finished products while ensuring absolute safety.

Innov’ia, a European expert in powder formulation, supports this process with production lines inspected by the ANSM (French National Agency for Medicines and Health Products Safety) and advanced CDMO expertise. From proof of concept to industrial scale-up, we put our know-how at the service of your pharmaceutical and nutraceutical innovations.

Challenges in Pharmaceutical and Health Product Formulation

Safety, Compliance, and Precise Dosing

In the health sector, there is no margin for error. Manufacturers must ensure perfect powder homogeneity and accurate active dosing to guarantee therapeutic efficacy. In addition, compliance with Good Manufacturing Practices (GMP) and IPEC standards for excipients is a prerequisite for global market access.

Active Stability and Bioavailability

Many active ingredients (vitamins, peptides, proteins, micro-organisms) are sensitive to oxidation, humidity, or temperature variations. Maintaining stability throughout shelf life and ensuring targeted release in the body (bioavailability) are major technological challenges for R&D departments.

Innov’ia’s CDMO Expertise Serving Health Products

produits pharmaceutiques et de santé

Support from R&I to Industrial Production

Innov’ia positions itself as a strategic co-development partner. Thanks to our R&I center and 45 experts, we address technological challenges from the laboratory stage. This support continues through custom production at our 4 industrial sites, ensuring a smooth and secure transition from pilot to mass production.

Technology Combination: Advanced Technological Mastery

To address the specific challenges of health products, Innov’ia deploys a full range of processes:

  • Microencapsulation: Ideal for trapping biological materials (micro-organisms, cells, peptides, proteins) and protecting actives from degradation.
  • Spray Drying: To convert liquid actives into stable and homogeneous powders.
  • Coating and Prilling: For masking bitter-tasting actives or achieving delayed release.
  • Fluidized Bed Granulation and Agglomeration: To improve powder flowability and dispersibility, facilitating final dosage form manufacturing (tablets, capsules).

Solutions Tailored to Every Health Application

Innov’ia works with a wide variety of products, adding tangible value at every transformation step:

Pharmaceutical and biological actives

Stabilization of fragile peptides, enzymes, and micro-organisms.

High-performance excipients

Custom excipient development to improve formulation physical properties.

Nutraceutical ingredients

Protection of vitamins (A, C, etc.) and minerals to ensure efficacy until expiry.

Health & wellness

Organoleptic masking and improved solubility for oral powders and dietary supplements.

Quality, ANSM, and Compliance with International Standards

Quality is at the heart of Innov’ia’s DNA. Our facilities and processes are rigorously audited to meet global requirements:

  • ANSM Inspection: Production lines qualified for health products.
  • Global Certifications: IPEC, FSSC 22000, and compliance with Good Manufacturing Practices (GMP).
  • Specific Certifications: Halal, Kosher, and Organic (Agriculture Biologique) available on request.
  • Confidentiality: Strict respect for intellectual property and contractual commitments.

Why Choose Innov’ia for Your Health Projects?

Historical expertise

Over 30 years of experience handling complex powders.

Innovation capacity

An R&I team of 45 experts able to design unique formulation solutions.

Industrial capacity

Flexible production across 4 certified sites.

Environmental commitment

€7 million invested to minimize impact and ensure responsible production.

Let’s Discuss Your Health Project

Are you developing a new pharmaceutical active, an innovative excipient, or a nutraceutical solution? Our experts are available to assess project feasibility and provide tailored support from laboratory to industrial scale.

FAQ: Pharmaceutical and Health Products

Innov’ia’s scale-up process is governed by a rigorous quality management system. From process validation at the R&I center to production on ANSM-inspected lines, each step is documented to ensure GMP compliance. This support facilitates preparation of marketing authorization (MA) or regulatory compliance dossiers.

The bitterness of some actives can hinder compliance, especially in children. We use microencapsulation to achieve precise taste masking. By isolating the active in a neutral membrane, undesired tastes and odors are neutralized while preserving the release kinetics, facilitating medication intake.

Absolutely. With 45 experts, we adapt technologies to minimize thermal and mechanical stress. Spray drying removes water from a solution while maintaining moderate temperature at the particle core, preserving protein structural integrity and biological activity of encapsulated enzymes or cells.

Controlled release regulates the active’s diffusion in the body (prolonged, delayed, or targeted), reducing dosing frequency, improving therapeutic efficacy, and limiting side effects. Learn more about our controlled-release solutions and how they enhance health product performance.

Yes, Innov’ia offers integrated services including complete physical and chemical analyses (particle size, density, morphology, stability). These rigorous checks ensure that each batch produced across our 4 sites meets the technical and pharmaceutical specifications defined during co-development.

Table of contents

Share this article:

Contact-us

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
I prefer to be contacted: